Clinical Trial Update: Contraception and Menstrual Cycle Effect on Pharmacokinetics, Pharmacodynamics and Safety in Tenofovir Vaginal Gel Use [Phase 1]

View source ↗

Summary

Phase 1 clinical trial assessing how contraception and the menstrual cycle influence pharmacokinetics, pharmacodynamics, and safety of tenofovir vaginal gel for…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• Tenofovir vaginal gel (tenofovir)

Snippet

Sponsor: CONRAD | Conditions: HIV Prevention | Phase 1 | Status: COMPLETED